Enaltus, LLC has sold its brand ScarAway® to Perrigo Company plc
August 2015 — Enaltus, LLC, a portfolio company of HealthEdge Investment Partners, LLC, has sold ScarAway®, a leading US over-the-counter (OTC) scar management brand, to Perrigo Company plc. Financial details have not been disclosed.
ScarAway® is a market leader in the scar management category in the OTC consumer channel. It is the fastest-growing brand in the category and is currently the number one 100% silicone scar treatment brand and the number two brand in the overall consumer scar category in the US. ScarAway® provides a complete range of scar management solutions, including gels, serum and long and short fabric-backed silicone sheets. The brand has distribution across all retailers in the drug, mass, food, specialty and e-commerce channels, with a presence in more than 35,000 doors in the US.
Founded in 1887 and headquartered in Dublin, Ireland, Perrigo Company plc (NYSE:PRGO), together with its subsidiaries, develops, manufactures, markets, and distributes OTC consumer goods and pharmaceutical products worldwide. It offers its products in various categories, including cough, cold, allergy and sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic products, natural health and vitamins, personal care and derma-therapeutics, lifestyle, and anti-parasite; consumer healthcare products; and vitamins, minerals, and supplements. The company sells its products through retail drug, supermarket, mass merchandise chains, wholesalers, pharmacies, drug and grocery stores, parapharmacies and hospitals as well as through a network of pharmacy sales force and pharmacists in North America, Europe, Australia, Israel, China, and Latin America.
Founded in 1995 and based in Suwanee, Georgia, Enaltus develops, manufactures and markets skincare products for professional and consumer markets primarily for mothers and babies in the US and internationally. The company’s products include Kelo-cote, a topical silicone gel and spray for the treatment and prevention of abnormal scars, including hypertrophic scars and keloids; bioCorneum, a silicone treatment for minimizing the appearance of scars; Belli, a skincare cosmetic for expecting and nursing mothers, and babies; and CapriClear Moisturizing Spray, a solution that provides relief from dry, flaky, and irritated skin. Enaltus also offers Arnika Forte, a natural supplement for recovering from bruising, swelling, and pain associated with soft tissue injuries. The company serves physicians, plastic surgeons, dermatologists, OB/GYN’s and others. It offers its products directly to physicians and consumers as well as through national and independent retailers.
Our role in the transaction
Oaklins' team in Los Angeles acted as advisor to Enaltus, LLC in this transaction.
Talk to the deal team
Steven Davis
Oaklins Intrepid
Related deals
Comtax has been acquired by Ryan
Comtax, a São Paulo-based tax technology consultancy specializing in tax determination and digital tax compliance, had been acquired by Ryan, the world’s largest firm dedicated exclusively to business taxes. The transaction marks Ryan’s entry into the Brazilian market, adding a specialized team and an established base of large corporate clients in Brazil, one of the world’s most complex tax environments, at a time when the country’s consumption tax reform is set to reshape how companies calculate and report indirect taxes. For Comtax, the acquisition brings access to Ryan’s global platform, technology and client network across more than 80 countries, creating opportunities to scale its tax determination and compliance offering beyond its current footprint. Comtax’s founders will continue to lead the business.
Learn moreCibus has acquired Aweta from Standard Investment
Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.
Learn moreGroGlass has been acquired by Apogee Enterprises
Apogee Enterprises, Inc. (Nasdaq: APOG), a leading US provider of architectural building products, services and high-performance coated materials, has acquired GroGlass, a Latvia-based developer and manufacturer of high-performance anti-reflective and UV-protective glass coatings. The acquisition brings GroGlass’ differentiated coating technologies and materials science expertise into Apogee’s performance surfaces segment, broadening its product offering and market reach while expanding its manufacturing and R&D presence in Europe.
Learn more